Amwell receives continued listing standard notice from nyse

Boston, april 04, 2024 (globe newswire) -- amwell ® (nyse: amwl), a leading provider of healthcare software as a service, today announced that it received a notice on april 2, 2024 from the new york stock exchange (nyse) informing the company that it is not in compliance with the nyse's continued listing minimum price criteria with respect to its class a common stock because the average closing price of the company's class a common stock was less than $1 per share over a consecutive 30 trading-day period. the notice does not result in the immediate delisting of the company's class a common stock from the nyse.
AMWL Ratings Summary
AMWL Quant Ranking